Phage display links a protein, antibody, or peptide to the gene that encodes it. The binding molecule is fused to a phage coat protein and displayed on the phage surface, so each phage carries both the displayed variant and the DNA that defines it. Panning the library against a target enriches the phages that bind, and because the sequence travels with the binder, the enriched hits can be recovered and identified directly. This coupling of binding to sequence is what makes phage display a productive discovery platform.
A discovery program needs work at both ends of the process: a library good enough to contain the answer, and a selection strategy that can find it. We provide both. Libraries can be constructed in several formats, including whole-antibody fragments and engineered protein scaffolds or constrained peptides, and they can be mined for a range of objectives — general high-affinity binding, or a specific behavior a project requires, such as cell entry, thermal stability, or single-domain (VHH) screening. The services below are organized so a project can be matched to the library and the selection it needs, including the site's existing VHH screening page where a single-domain binder is the goal.
| Service | What it delivers | Typical goal |
| Phage Display Library Construction | Antibody libraries in Fab or scFv format | Build a library from an immune or natural source |
| Engineered Scaffold Library Construction | Scaffold-based libraries in a chosen display system | Non-immunoglobulin binders with a stable framework |
| Constrained Peptide Library Construction | Defined sets of synthetic peptides | Epitope mapping and functional peptide screening |
| Internalizing Antibody Screening | Antibodies that enter cells by receptor-mediated uptake | Payload delivery and internalizing therapeutic leads |
| Thermostable scFv/Fab Screening | Fragments selected for high melting temperature | Reagents that must survive demanding conditions |
| Protease Substrate Screening | Peptide substrates that define protease specificity | Substrate discovery and inhibitor design |
| Fully Human Antibody Preparation | Fully human antibodies from human libraries | Lead discovery with low immunogenicity |
| VHH Antibody Screening | Single-domain VHH antibodies screened by phage display | Small, stable binders from camelid-derived libraries (existing site page) |
Because construction and screening share one logic — represent the target in the library, then select for the behavior the project needs — a discovery program can be run as a single continuous effort. Whether the answer is expected to be an antibody fragment, an engineered scaffold, or a peptide, the same reasoning connects the library that is built to the selection that is applied, keeping the work coherent from first design to validated molecule.